Introduction
In recent decades health care has improved, and at the same time the elderly population has increased w1x. Even the definition of the 'elderly' population has changed, with a cut-off rising from 65 years to 70 years or more w2, 3x, and lung cancer incidence in older patients has increased also w4x. Despite several studies regarding lung resection in the older population having dismissed previous accounts of prohibitively high mortality rates, and having suggested that surgical resection is associated with a reasonable perioperative risk, only a few of them deal with patients over 80 years old w5-10x. To better understand the real benefit of surgical treatment in octogenarians with nonsmall cell lung cancer (NSCLC), and to determine what should be done or avoided during the selection course, we retrospectively analysed our recent nine-year experience and compared it with those of the literature. The main aim of this study was to evaluate postoperative surgical and oncological outcomes, investigating their relationship with data from the preoperative evaluation course, surgical management and pathological findings.
Materials and methods

Study design and definitions
All cases were re-staged according to the seventh edition of the TNM classification w11x.
To identify the individual comorbid ailments and define the severity of comorbid health, in such a limited number of patients, we utilised a new 27-item validated comorbidity index for use in patients with cancer (ACE-27) w12x. For 1 the evaluation of preoperative and postoperative quality of life, we utilised the Karnofsky Performance Status (KPS) scale.
Treatment-related complications were defined as those occurring within 30 days of treatment. Minor complications were those resulting in no sequelae or in a short hospital stay for observation (-10 days). Major complications were those resulting in re-admission to the hospital for treatment, an unplanned increase in the level of care, extended hospitalisation ()10 days), permanent adverse sequelae, or death.
Statistical analysis
Statistical analysis was performed using Statistica software version 6.0 for the personal computer (PC) (Stat-Soft, Adult Comorbidity Evaluation 27 (ACE-27). COPD, chronic obstructive pulmonary disease; coronary artery disease was defined as a positive exercise testing or prior myocardial infarction or prior coronary bypass. 
Results
Demographics and clinical data
During the period, of the )3000 patients that underwent pulmonary resection of NSCLC at our Institute, 82 were older than 80 years of age. There were 63 males and 19 females with a mean age of 81.1 years (range 80-87 years). Most of the patients were asympomatic and lung cancer was revealed on an occasional chest X-ray. Preoperative performance status, according to the Karnofsky scale, was 82% on average (range 70%-100%). The mean preoperative FEV value was 1.74 l (range 1.1-2.4). In 28 cases (34.1%), 1 estimation of T and quantitative perfusion scan were LCO performed in addition to routine lung function test. Most patients (77.8%) exhibited comorbidities, and 25 patients (30.5%) had two or more comorbid conditions ( Table 1) . Based on the ACE-27 scoring system, 18 patients were evaluated to be grade 0, 38 patients grade 1, 19 patients grade 2, and seven patients grade 3. Routine staging included chest radiograph, bronchoscopy, blood tumour markers, CT of the chest and upper abdomen in all cases. In nine cases, brain CT or bone scintigraphy excluded disseminate disease. Mediastinoscopy (ns7) or TBNA (ns10) were negative in 17 patients with enlarged mediastinal nodes ()1 cm). Preoperative pathological diagnosis was obtained in 35 (42.6%) cases: seven adenocarcinomas, eight squamous cell carcimanomas and 20 less well-established NSCLCs. Preoperative staging is summarised in Table 2 . No patients underwent neo-adjuvant chemotherapy or radiation therapy.
Surgical data
Under general anaesthesia with double lumen intubation, 63 (76.8%) lobectomies, one (1.2%) inferior bilobectomy, three (3.7%) segmentectomies and 15 (18.3%) wedge resections were performed. No pneumonectomy was recorded in octogenarians. Two left upper lobectomies were en bloc due to chest wall invasion. In one case a right upper extrapleural lobectomy was performed because of infiltration of the parietal pleura. There were three bronchial sleeve lobectomies (two right upper lobectomies and one left upper lobectomy) and one arterial sleeve left upper lobectomy. Seven lobectomies and nine wedge resections were performed by VATS.
Postoperative histology and staging
Pathologic evaluation revealed 33 adenocarcinomas, 36 squamous cell carcinomas, seven bronchiolar-alveolar carcinomas, and six large cell carcinomas. Pathologic TNM stage confirmed the preoperative clinical staging in 50 (61.0%) cases ( Table 2) . Stage IIIA disease was due to unexpected N2 disease in 14 cases, while in the other two cases it was due to T3 N1 disease.
Mortality and morbidity analysis
Two deaths occurred in patients that underwent lobectomy, with an overall perioperative mortality rate of 2.4%. In one case it was for acute myocardial infarction on the second postoperative day, and in the second case for acute respiratory failure on first postoperative day. The overall morbidity rate was 30.4%. Major complications occurred in two patients that underwent lobectomy. One case of brain transient ischemic attack, and another case of cardiac arrest promptly and successfully reanimated. In these two cases hospital stay was prolonged until the 13th and the 15th postoperative day, respectively. No patients that underwent sublobar resection had major complications.
One or more minor complications occurred in 22 patients ( Table 3 ). The median overall postoperative hospital stay for the 80 surviving patients was 7.1 days (range 4-21 days). Table 4 summarises the risk factor analysis results. Male gender was associated with a higher overall morbidity (Ps0.0236), but not with higher mortality (Ps0.432). In contrast, ACE-27 grade was strongly related with mortality (Ps0.003), but also with major and minor (Ps0.03 and Ps0.05, respectively). A borderline correlation was observed between mortality and type of approach (thoracotomy vs. VATS) (Ps0.057). The extent of resection, instead, significantly influenced mortality (Ps0.0356), and a trend to correlation was observed with minor complications (prevalently prolonged air leaking)(Ps0.056). A strong statistically-significant difference in postoperative hospital stay was revealed comparing ACE-27 score (Ps0.0015). Multivariate analysis confirmed ACE-27 score as an independent predictor of postoperative morbidity (Ps0.001), mortality (ACE-27 grade 3, Ps0.00015) and hospital stay (Ps0.008).
Risk factor analysis
Follow-up and survival analysis
At the time of analysis, 34y80 (42.5%) patients were alive: 28 were disease-free, five had local disease recurrence, one had local and distant recurrence. There were only three cases with a deterioration in the quality of life, corresponding to a KS of 60%, due to the progression of Alzheimer's disease. In the 46 patients who died during the follow-up period, death was cancer-related (CR) in 28 (60.1%) of the cases. At a mean follow-up of 47 months (range 11-94 months, median 48 months), the overall and CR median survival were 30.9 and 34.5 months, respectively. Actuarial overall and CR survival at one, three and five years were 87%, 37% and 27%, and 90%, 44% and 36%, respectively (Fig. 1) . There was no statistically-significant association between survival and co-morbidity grade, FEV 1 value, extent of resection, type of approach, histology (Fig.  2) . On the contrary, long-term overall and CR survival were closely associated with pathologic stage (Ps0.016 and Ps0.00003, respectively) (Fig. 3) .
Discussion
In European countries the population is ageing, so the number of elderly patients with potentially resectable NSCLC is concomitantly increasing w4x. In a recent paper Janssen and Kunst found that by 2050 the average further life expectancy of people reaching 80 years of age is predicted to be 9.16 years for men and 12.65 for women w1x. Based on these data, it is likely that the greatest impact on an octogenarian's survival will be their CR mortality rather than their age alone. During the past few years, some papers regarding lung resections in the octogenarian seem to dismiss the older accounts of prohibitively high mortality and morbidity w5-8x. This seems to be confirmed in our analysis, where we obtained an acceptable mortality and morbidity rate of 2.4% and 30.4%, respective- ly, which are comparable with those reported by recent studies, ranging between 0%-8.8% and 18-49%, respectively w5-9x.
Not many studies analysed risk factors predicting morbidity and mortality. Dominguez-Ventura and co-workers, in a large study, reported that a FEV value of 40% or less than 1 predicted was not associated with higher mortality, but it increased the incidence of morbidity w10x. In contrast, Pagni et al. reported no significant difference in perioperative risk when patients were stratified by abnormal pulmonary function test (FEV -60% of predicted value) w9x. Moreover, 1 both Brock et al. and Port et al. observed no correlation between morbidity and pulmonary function w5, 8x. Our statistical analysis also revealed that a preoperative FEV 1 value -1.5 l was not related with a higher incidence of mortality and morbidity.
In our analysis, the most important risk factor that affected mortality and morbidity was the presence of serious comorbidity conditions (ACE-27 grade 2-3). Port et al. analysed postoperative complications in function of the presence of single or multiple comorbidities, without achieving statistical significance w5x. Other papers did not provide a statistical analysis of risk factors, reporting solely a lack of statistical significance for an unspecific comorbid condition w8, 9x. Nevertheless, the methodical analysis of a single comorbidity presented by Doninguez-Ventura et al. emphasised that only the presence of congestive heart failure and prior myocardial infarction were related with higher mortality, while some comorbid conditions affected morbidity w10x. Unfortunately, a comparison with our results becomes difficult because of the different modalities of comorbidities stratification.
The survival data in our study revealed a five-year overall survival rate of 27%, which increased to 36% if we consider CR survival. Such result, at the lower-level of those reported by authors in western countries, which ranged between 34% and 43% w5-8x, is probably affected by an unexpectedly high incidence of stage III disease. This could be referred to a lack of extensive use of brain CT or MR, PET-CT, mediastinoscopy in our institute. Few studies investigated the predictive factors regarding increased survival. Brock et al. reported that a FEV -1.5 l and the ASA class 1 affected survival w8x. In the large study by DomingezVentura et al. w7x, as well as in the present paper, there was no difference in survival according to FEV value. On 1 the contrary, our analysis confirmed the well-known correlation between pathologic stage and survival w5-8x, achieving a five-year CR survival rate of 52% for stage IyII.
Our study has some limitations. The first one is that we report a single centre experience. Another very significant one is the retrospective nature of the study, which may have resulted in a selection bias. Additionally, we did not analyse single comorbidity in different organs, because the small number of patients made the choice to evaluate the general clinical status, attempting to quantify a global operative risk, that was the result of each single disorder occurring in different organs.
In conclusion, surgical resection of NSCLC in elderly patients resulted as being safe, with acceptable long-term survival. When surgeons have to take the controversial decision of whether to offer resection to octogenarians, they should base their choice first on the stage of the disease, and then on an accurate assessment of the general clinical conditions, rather than on pulmonary function alone. In this sense, the ACE-27 scoring system seems to be useful to track those patients with a high multi-factorial operative risk. We read with great interest the article by Fanucchi et al. as we are supporters of the trend suggesting that appropriately selected octogenarians should not be excluded from surgical treatment w1x. However, since it is our practice too, we are very much interested in further information regarding patient characteristics. In particular, it would be very useful to our practice to have insight into survival in relation to the histological type of carcinoma, especially large cell carcinomas which seem to be a whole new entity with poor prognosis w2, 3x.
Our concluding point is that there are hundreds of factors influencing prognosis many of which are established as prognostic w4x. But since we are referring to a new target age group and the operability guidelines, we have to consider new, age-specific parameters for our practice, e.g excluding patients with large cell carcinomas if survival proves to be low after surgical treatment.
